National Human Genome Research Institute; Notice of Closed Meeting, 2868 [05-878]
Download as PDF
2868
Federal Register / Vol. 70, No. 11 / Tuesday, January 18, 2005 / Notices
Place: Sheraton Columbia Hotel, 10207
Wincopin Circle, Columbia, MD 21044.
Contact Person: Katherine M. Malinda,
PhD, Scientific Review Administrator,
Review Branch, Division of Extramural
Affairs, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6701
Rockledge Drive, Room 7198, Bethesda, MD
20892, 301/435–0297.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: January 11, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–945 Filed 1–14–05; 8:45 am]
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Review of
Research Project (RO1) Applications.
Date: January 25, 2005.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: William J. Johnson, PhD,
Review Branch, Division of Extramural
Affairs, National Heart, Lung and Blood
Institute, National Institutes of Health, 6701
Rockledge Drive, Room 7184, MSC 7924,
Bethesda, MD 20892, 301/435–0275.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Jkt 205001
Dated: January 11, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–948 Filed 1–14–05; 8:45 am]
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Human Genome Research
Institute; Notice of Closed Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
11:51 Jan 14, 2005
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4140–01–M
VerDate jul<14>2003
Sleep Disorders Research; 93.937, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice
is hereby given of a meeting of the
Board of Scientific Counselors, NIAID.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), title 5 U.S.C., as amended for
the review, discussion, and evaluation
of individual intramural programs and
projects conducted by the National
Institute of Allergy and Infectious
Diseases, including consideration of
personal qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Human
Genome Research Institute Initial Review
Group Genome Research Review Committee.
Date: March 8, 2005.
Time: 11:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Ken D. Nakamura, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Human Genome
Research Institute, National Institutes of
Health, Bethesda, MD 20892, 301–402–0838.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Name of Committee: Board of Scientific
Counselors, NIAID, Vaccine Research Center,
Board of Scientific Counselors.
Date: February 7–8, 2005.
Time: February 7, 2005, 1 p.m. to 6 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 40, 40 Convent Drive, Bethesda, MD
20892.
Time: February 8, 2005, 9 a.m. to 2:30 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 40, 40 Convent Drive, Bethesda, MD
20892.
Contact Person: Gary J. Nabel, MD, PhD,
Investigator, Vaccine Research Center,
NIAID/NIH, 40 Convent Drive, Bldg 40,
Room 4502, Bethesda, MD 20892, 401–496–
1852, gnabel@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 10, 2005.
Anna P. Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–878 Filed 1–14–05; 8:45 am]
Dated: January 10, 2005.
Anna P. Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–879 Filed 1–14–05; 8:45 am]
BILLING CODE 4140–01–M
BILLING CODE 4140–01–M
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
E:\FR\FM\18JAN1.SGM
18JAN1
Agencies
[Federal Register Volume 70, Number 11 (Tuesday, January 18, 2005)]
[Notices]
[Page 2868]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-878]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Human Genome Research Institute
Initial Review Group Genome Research Review Committee.
Date: March 8, 2005.
Time: 11:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5635 Fishers Lane,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Ken D. Nakamura, PhD, Scientific Review
Administrator, Office of Scientific Review, National Human Genome
Research Institute, National Institutes of Health, Bethesda, MD
20892, 301-402-0838.
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human
Genome Research, National Institutes of Health, HHS)
Dated: January 10, 2005.
Anna P. Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-878 Filed 1-14-05; 8:45 am]
BILLING CODE 4140-01-M